Glossary Updates16 new terms added to the glossaries · November 12, 2026, 21:23 CET
AI TechDocKnowledge
  • English (US)
  • English (UK)
  • Deutsch
All context cards

Role card

Clinical evidence owner: a functional role

Who keeps the clinical and performance evidence of a device in step with the IFU, the claims and the post-market data?

A role card explains a functional role: what has to be done, not a job title. One person can hold several of them, and one can be spread over several people.

By knowledge.aitechdoc.world

Reviewed

Review log and changes

The short answer

The clinical evidence owner keeps the clinical evaluation (or the performance evaluation for IVDs) current and names the clinical benefits, performance figures and safety endpoints as objects the IFU, the summary and the claims refer to. The role updates them from PMCF and confirms which evidence a claim may rest on; the clinical judgment itself stays with qualified evaluators.

For: Technical writers, technical marketers, project managers and documentation systems developers in medical device companies

Key points

  • Clinical benefits and performance figures are named objects, not sentences copied into brochures.
  • PMCF or PMPF updates the evidence and everything that cites it.
  • Linking a claim to a study doesn’t make the data sufficient.

Functional role

Clinical evidence owner

The role in one sentence

The functional role that keeps the clinical or performance evaluation current and makes its benefits, figures and endpoints referable from every document that uses them.

Responsibilities

  • Keep the clinical evaluation plan and report (or performance evaluation) current.
  • Name clinical benefits, performance figures and safety endpoints with ids.
  • Confirm the evidence behind each claim.
  • Feed PMCF or PMPF results into the evaluation and the documents that cite it.

Decides

  • Which figures and benefits the evaluation supports
  • Whether new data changes a conclusion

Does not decide

  • The wording of claims (claims matrix)
  • The intended purpose
  • The release of the IFU

Receives

  • Clinical investigations and literature
  • PMCF and real-world data
  • Validation data of software functions

Hands over

  • Clinical evaluation report
  • Named evidence objects
  • Evidence confirmations for claims

Typically held by

Reader roles of the pathway map that usually take on this function.

Technical writers
Uses the named figures in the IFU instead of copying numbers.
Technical marketers
Asks for the evidence object behind every claim.
Technical project managers
Plans PMCF updates with the release cycle.
Documentation systems developers
Makes evidence objects referable by id.

On the map

The context

Where the role acts

The role belongs to the pathway map of the medical-device evidence chain. It acts at these stations:

  • Clinical and performance evidence — Keeps clinical benefits, performance and safety endpoints as named objects.
  • Claims as controlled information — Confirms which evidence a claim may rest on.
  • Training data provenance — Treats validation data as part of the clinical evidence.

Why a functional role

The functional role that keeps the clinical or performance evaluation current and makes its benefits, figures and endpoints referable from every document that uses them. One person can hold several functional roles, and one role can be spread over several people. What matters is the test: who can decide or change something here — and who can’t?

The map and this role describe documentation work; they don’t confer conformity.

Questions readers ask next

Is “Clinical evidence owner” a job title?
No. Not the qualified evaluator’s clinical judgment, which stays with that person. The map describes what has to be done, not who does it on the org chart.
What does the role not decide?
The wording of claims (claims matrix); The intended purpose; The release of the IFU.

Sources

  1. Regulation (EU) 2017/745 on medical devices (MDR) — EUR-Lex, May 5, 2017Law in force: Binding legislation that applies as of the review date.
  2. Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) — EUR-Lex, May 5, 2017Law in force: Binding legislation that applies as of the review date.
  3. MDCG endorsed documents, incl. MDCG 2025-6 (interplay between the MDR/IVDR and the AI Act) and MDCG 2019-11 (software qualification and classification) — European Commission, June 2025Final guidance: Guidance published in its final form by an authority or an official body. Guidance explains the law; it is not law itself.

Review log and changes

Every context card is checked against its sources before it is published, and again whenever it changes; the date under the byline is the last review. Corrections (something was wrong) and additions (something was missing) are logged below with date and time (Berlin time). Typos, formatting and link fixes are not listed.

Reviewed

No corrections or additions since publication.